• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膝下病变所致严重肢体缺血的血运重建策略——首先应选择哪种,旁路手术还是血管内治疗?

Strategy of Revascularization for Critical Limb Ischemia Due to Infragenicular Lesions-Which Should Be Selected Firstly, Bypass Surgery or Endovascular Therapy?

作者信息

Ohmine Takahiro, Iwasa Kazuomi, Yamaoka Terutoshi

机构信息

Department of Vascular Surgery, Matsuyama Red Cross Hospital, Matsuyama, Ehime, Japan.

出版信息

Ann Vasc Dis. 2015;8(4):275-81. doi: 10.3400/avd.oa.15-00076. Epub 2015 Sep 11.

DOI:10.3400/avd.oa.15-00076
PMID:26730251
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4691500/
Abstract

BACKGROUND AND OBJECTIVES

In patients with peripheral arterial diseases (PADs) due to infra-popliteal (below the knee; BTK) lesions, we often encounter situations requiring the immediate selection of either of two revascularization methods, namely bypass surgery or endovascular therapy (EVT). However, the question of whether endovascular or surgical revascularization should be performed initially for critical limb ischemia (CLI) patients with BTK lesions has not been clarified. To assess the efficacy and durability of EVT or bypass as a first approach, we evaluated the short- and mid-term outcomes of the first revascularizations achieved using EVT (EVT First Group; EVT-first) compared with bypass (Bypass First Group; Bypass-first). To verify the validity of each initial revascularization, we explored factors influencing overall survival (OS) rates using multivariate analyses.

METHODS

A total of 169 consecutive BTK revascularization procedures (150 patients) for CLI conducted at our facility between November 2006 and July 2012 were analyzed. Patients undergoing revascularization were divided into two groups (EVT-first or Bypass-first), with 102 patients undergoing endovascular therapy first (EVT-first) and 51 undergoing bypass surgery first (Bypass-first). No statistically significant differences were noted between the two groups with respect to preoperative background including age, gender, and cardiovascular risk factors (hypertension, diabetes, hyperlipidemia, coronary arterial disease (CAD), chronic heart failure (CHF), cerebrovascular disease, and hemodialysis). Technical success was defined as a single straight-line flow to the ankle after completion angiography of the first revascularization method. Hemodynamic success was defined as a postoperative skin perfusion pressure of the foot exceeding 40 mmHg.

RESULTS

The average age of patients was 76.0 years (range, 46-98 years; 65 men and 37 women) and 72.3 years (range, 43-93 years; 35 men and 13 women) in the EVT-first and Bypass-first groups, respectively. Patient follow-up ranged from 1 to 50 months (mean, 15 months). Respective technical and hemodynamic success rates were 96.2% and 66.7% for EVT-first and 100% and 94% for Bypass-first, respectively. Treatment was required an average of 1.5 times for EVT-first and 1.2 times for Bypass-first. Respective rates for other factors examined in the EVT-first and the Bypass-first groups were: major amputation rates 30 days post-procedure, 5.9%, and 3.9%; mortality rates 30 days post-procedure, 3.9%, and 0%; one-year AFS rates, 71.7%, and 79.5%; OS rates, 73.5% and 83.9%; and limb salvage rates, 88.8%, and 91.0%. Multivariate-analysis of all subjects in the two groups revealed that the OS rates were affected by four risk factors as follows: (1) age greater than 80 years, (2) CAD, (3) CHF, and (4) a non-ambulatory limb.

CONCLUSION

For patients with CLI due to BTK lesions and whose saphenous veins are in poor condition or are in poor general condition having two or more of the four severe risk factors, the EVT-First procedure is effective and provides durable results. Overall survival in patients with CLI due to BTK lesions is worse when patients have more than two severe risk factors, which is non-ambulatory limb, aged less than 81 years, with CAD or with CHF. (This article is a translation of Jpn J Vasc Surg 2014; 23: 766-773.).

摘要

背景与目的

在因腘动脉以下(膝下;BTK)病变导致外周动脉疾病(PAD)的患者中,我们经常遇到需要立即选择两种血管重建方法之一的情况,即旁路手术或血管内治疗(EVT)。然而,对于患有BTK病变的严重肢体缺血(CLI)患者,应首先进行血管内还是外科血管重建的问题尚未明确。为了评估EVT或旁路作为首选方法的疗效和持久性,我们评估了与旁路(旁路优先组;旁路优先)相比,使用EVT(EVT优先组;EVT优先)实现的首次血管重建的短期和中期结果。为了验证每次初始血管重建的有效性,我们使用多变量分析探索了影响总生存率(OS)的因素。

方法

对2006年11月至2012年7月在我们机构进行的169例连续的CLI的BTK血管重建手术(150例患者)进行了分析。接受血管重建的患者分为两组(EVT优先或旁路优先),102例患者首先接受血管内治疗(EVT优先),51例患者首先接受旁路手术(旁路优先)。两组在术前背景(包括年龄、性别和心血管危险因素(高血压、糖尿病、高脂血症、冠状动脉疾病(CAD)、慢性心力衰竭(CHF)、脑血管疾病和血液透析))方面没有统计学上的显著差异。技术成功定义为首次血管重建方法完成血管造影后至踝关节的单一直线血流。血流动力学成功定义为术后足部皮肤灌注压超过40 mmHg。

结果

EVT优先组和旁路优先组患者的平均年龄分别为76.0岁(范围46 - 98岁;65名男性和37名女性)和72.3岁(范围43 - 93岁;35名男性和13名女性)。患者随访时间为1至50个月(平均15个月)。EVT优先组的技术成功率和血流动力学成功率分别为96.2%和66.7%,旁路优先组分别为100%和94%。EVT优先组平均需要治疗1.5次,旁路优先组平均需要治疗1.2次。EVT优先组和旁路优先组中其他检查因素的各自发生率如下:术后30天的大截肢率分别为5.9%和3.9%;术后30天的死亡率分别为3.9%和0%;一年的AFS率分别为71.7%和79.5%;OS率分别为73.5%和83.9%;肢体挽救率分别为88.8%和91.0%。对两组所有受试者的多变量分析显示,OS率受以下四个危险因素影响:(1)年龄大于80岁,(2)CAD,(3)CHF,(4)非行走肢体。

结论

对于因BTK病变导致CLI且大隐静脉状况不佳或总体状况不佳且有四个严重危险因素中的两个或更多的患者,EVT优先手术是有效的且能提供持久的结果。当患有BTK病变的CLI患者有两个以上严重危险因素,即非行走肢体、年龄小于81岁、患有CAD或患有CHF时,其总体生存率较差。(本文是对《日本血管外科学杂志》2014年;23: 766 - 773的翻译。)

相似文献

1
Strategy of Revascularization for Critical Limb Ischemia Due to Infragenicular Lesions-Which Should Be Selected Firstly, Bypass Surgery or Endovascular Therapy?膝下病变所致严重肢体缺血的血运重建策略——首先应选择哪种,旁路手术还是血管内治疗?
Ann Vasc Dis. 2015;8(4):275-81. doi: 10.3400/avd.oa.15-00076. Epub 2015 Sep 11.
2
Efficacy of statin treatment after endovascular therapy for isolated below-the-knee disease in patients with critical limb ischemia.他汀类药物治疗对严重肢体缺血患者膝下孤立性疾病血管内治疗后的疗效。
Cardiovasc Interv Ther. 2013 Oct;28(4):374-82. doi: 10.1007/s12928-013-0188-6. Epub 2013 Jun 12.
3
Clinical outcomes of endovascular treatments for critical limb ischemia with chronic total occlusive lesions limited to below-the-knee arteries.局限于膝下动脉慢性完全闭塞病变的严重肢体缺血血管内治疗的临床结果
Acta Radiol. 2013 Sep;54(7):785-9. doi: 10.1258/ar.2012.120217.
4
[Effectiveness of endovascular therapy for critical limb ischemia].[血管内治疗对严重肢体缺血的疗效]
Nihon Geka Gakkai Zasshi. 2010 Mar;111(2):91-6.
5
Clinical Outcomes after Isolated Infrapopliteal Revascularization in Hemodialysis Patients with Critical Limb Ischemia: Endovascular Therapy versus Bypass Surgery.血液透析合并肢体严重缺血患者单纯腘下动脉血运重建的临床疗效:腔内治疗与旁路手术的比较。
J Atheroscler Thromb. 2018 Sep 1;25(9):799-807. doi: 10.5551/jat.42648. Epub 2018 Jan 23.
6
Outcomes of dialysis patients with critical limb ischemia after revascularization compared with patients with normal renal function.比较有严重肢体缺血的透析患者与肾功能正常的患者在血管重建术后的结果。
J Vasc Surg. 2018 Sep;68(3):822-829.e1. doi: 10.1016/j.jvs.2017.12.048. Epub 2018 Mar 26.
7
Predictors of 2-Year Mortality and Risk Stratification After Surgical or Endovascular Revascularization of Infrainguinal Artery Disease in Hemodialysis Patients With Critical Limb Ischemia.严重肢体缺血的血液透析患者股腘动脉疾病手术或血管腔内血运重建术后2年死亡率的预测因素及风险分层
J Endovasc Ther. 2015 Oct;22(5):719-24. doi: 10.1177/1526602815599413. Epub 2015 Aug 14.
8
Open bypass and endoluminal therapy: complementary techniques for revascularization in diabetic patients with critical limb ischaemia.开放旁路手术和腔内治疗:治疗严重肢体缺血糖尿病患者血管重建的互补技术。
Diabetes Metab Res Rev. 2008 May-Jun;24 Suppl 1:S34-9. doi: 10.1002/dmrr.829.
9
Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery.12年来严重肢体缺血外科血运重建方式的变化:血管腔内治疗与开放旁路手术对比
J Vasc Surg. 2006 Aug;44(2):304-13. doi: 10.1016/j.jvs.2006.03.040.
10
The relationship between sarcopenia and one-year mortality in patients with critical limb ischemia undergoing endovascular therapy below the knee.下肢血管腔内治疗的严重肢体缺血患者的肌肉减少症与一年死亡率之间的关系。
Vascular. 2023 Jun;31(3):513-520. doi: 10.1177/17085381221124702. Epub 2022 Sep 3.

引用本文的文献

1
Comprehensive Assessment of Current Management Strategies for Patients With Diabetes and Chronic Limb-Threatening Ischemia.糖尿病合并慢性肢体威胁性缺血患者当前管理策略的综合评估
Clin Diabetes. 2021 Oct;39(4):358-388. doi: 10.2337/cd21-0019.
2
Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee.亚太共识声明:外周动脉疾病管理:来自亚太动脉粥样硬化和血管疾病学会外周动脉疾病共识声明项目委员会的报告。
J Atheroscler Thromb. 2020 Aug 1;27(8):809-907. doi: 10.5551/jat.53660. Epub 2020 Jul 4.
3
Combined Direct Endarterectomy and Fogarty Thrombectomy with Endovascular Therapy for Subacute Occlusion of the Superficial Femoral Artery.联合直接动脉内膜切除术、Fogarty血栓切除术及血管内治疗用于股浅动脉亚急性闭塞
Ann Vasc Dis. 2019 Mar 25;12(1):63-65. doi: 10.3400/avd.cr.18-00104.
4
Distal Bypass to the Palmar Arch to Rescue Digital Ischemia Due to Peripheral Artery Disease.远端吻合至掌弓以挽救因外周动脉疾病导致的手指缺血
Ann Vasc Dis. 2018 Sep 25;11(3):335-338. doi: 10.3400/avd.cr.18-00011.
5
Comparison of perfusion values after percutaneous transluminal angioplasty according to the severity of ischaemia in the diabetic foot.比较糖尿病足缺血严重程度经皮腔内血管成形术后的灌注值。
Int Wound J. 2019 Feb;16(1):176-182. doi: 10.1111/iwj.13008. Epub 2018 Oct 12.
6
Current Status of Arterial Revascularization for the Treatment of Critical Limb Ischemia in Infrainguinal Atherosclerotic Disease.股动脉以下动脉粥样硬化疾病所致严重肢体缺血的动脉血运重建治疗现状
Int J Angiol. 2018 Sep;27(3):132-137. doi: 10.1055/s-0037-1620242. Epub 2018 Jan 22.
7
Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease.下肢动脉疾病初次血运重建策略中旁路和血管内介入治疗的患者选择和围手术期结局。
J Vasc Surg. 2018 Jan;67(1):206-216.e2. doi: 10.1016/j.jvs.2017.05.132. Epub 2017 Aug 24.

本文引用的文献

1
Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia.药物涂层球囊在膝下血管成形术评估中的外周介入治疗(DEBATE-BTK):糖尿病合并严重肢体缺血患者的随机试验。
Circulation. 2013 Aug 6;128(6):615-21. doi: 10.1161/CIRCULATIONAHA.113.001811.
2
Clinical efficacy of endovascular therapy for patients with critical limb ischemia attributable to pure isolated infrapopliteal lesions.腔内治疗对单纯累及腘下病变所致的临界肢体缺血患者的临床疗效。
J Vasc Surg. 2013 Apr;57(4):974-981.e1. doi: 10.1016/j.jvs.2012.10.096. Epub 2013 Feb 1.
3
Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up.腔内治疗在伴有严重肢体缺血患者的下肢血管中的应用:OLIVE 注册研究,一项日本的前瞻性、多中心研究,随访 12 个月。
Circ Cardiovasc Interv. 2013 Feb;6(1):68-76. doi: 10.1161/CIRCINTERVENTIONS.112.975318. Epub 2013 Jan 29.
4
Angiographic restenosis and its clinical impact after infrapopliteal angioplasty.下肢动脉腔内成形术后的血管造影再狭窄及其临床影响。
Eur J Vasc Endovasc Surg. 2012 Oct;44(4):425-31. doi: 10.1016/j.ejvs.2012.07.017. Epub 2012 Aug 28.
5
Contemporary outcomes after endovascular treatment for aorto-iliac artery disease.腔内治疗主髂动脉疾病的当代结果。
Circ J. 2012;76(11):2697-704. doi: 10.1253/circj.cj-12-0492. Epub 2012 Aug 2.
6
Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes.REACH 登记研究中缺血性截肢患者的结局:3 年心血管和肢体相关结局。
Atherosclerosis. 2012 Apr;221(2):527-35. doi: 10.1016/j.atherosclerosis.2012.01.002. Epub 2012 Jan 24.
7
2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.2011年美国心脏病学会基金会/美国心脏协会外周动脉疾病患者管理指南聚焦更新(更新2005年指南):美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2011 Nov 1;124(18):2020-45. doi: 10.1161/CIR.0b013e31822e80c3. Epub 2011 Sep 29.
8
Long-term results of the S.M.A.R.T. Control(TM) stent for superficial femoral artery lesions, J-SMART registry.S.M.A.R.T. Control(TM) 支架治疗股浅动脉病变的长期结果:J-SMART 注册研究。
Circ J. 2011;75(4):939-44. doi: 10.1253/circj.cj-10-1029. Epub 2011 Feb 11.
9
Understanding objective performance goals for critical limb ischemia trials.理解严重肢体缺血试验的客观绩效目标。
Semin Vasc Surg. 2010 Sep;23(3):129-37. doi: 10.1053/j.semvascsurg.2010.06.001.
10
Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.股腘动脉自膨式镍钛合金支架置入术后中期临床结果及血管通畅性的预测因素。
J Vasc Surg. 2010 Sep;52(3):608-15. doi: 10.1016/j.jvs.2010.03.050. Epub 2010 Jun 22.